Less Ads, More Data, More Tools Register for FREE

Pin to quick picksDiscoverIE Regulatory News (DSCV)

Share Price Information for DiscoverIE (DSCV)

Share Price is delayed by 15 minutes
Get Live Data
682.00    -3.00 (-0.44%)
Bid:
681.00
Ask:
684.00
Spread: 3.00 (0.441%)
Market Cap: £662.37m
DSCV Live PriceLast checked at - London Stock Exchange

Intraday DiscoverIE Share Chart

Aggreko

5 Aug 2021 17:30

RNS Number : 7552H
FTSE Russell
05 August 2021
 

 

 

 

Further to the FTSE Russell notice released on 03 August 2021 in relation to Aggreko (UK): Constituent Deletion, please note the FTSE 250 replacement.

 

All other details remain unchanged. Please see updated notice below:

 

Aggreko (UK): Constituent Deletion - UpdateChanges in FTSE UK Index Series

05 August 2021

Subject to court sanctioning the scheme of arrangement in relation to the cash offer for Aggreko (UK, constituent) by Albion Acquisitions Limited (non constituent), please see details of affected indexes and effective dates below:

 

Aggreko (UK, BK1PTB7) will be deleted from the FTSE 250 Index.

 

Discoverie Group (UK, 0005588) will be added to the FTSE 250 Index and deleted from the FTSE SmallCap Index.

 

All changes are effective from 10 August 2021.

 

Full details of index changes are available on the FTSE Russell website.

 

 

 

 

 

 

 

 

For further information please contact FTSE Russell Client Services at info@ftserussell.com or call:

Australia

+1800 653 680

Hong Kong

+852 2164 3333

Japan

+81 3 4563 6346

London

+44 (0) 20 7866 1810

New York

+1866 551 0617

 

Alternatively please visit our website at www.ftserussell.com

 

Terms of Use | Copyright © 2021 FTSE Russell

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
FTSEALPSEDAFEFA
Date   Source Headline
5th Sep 20232:17 pmRNSNotification of Major Holdings
31st Aug 20237:00 amRNSAcquisition completion - Silvertel
1st Aug 20237:00 amRNSAcquisition of Silvertel
24th Jul 20232:31 pmRNSResults of Annual General Meeting
24th Jul 20237:00 amRNSTrading Update
27th Jun 202310:53 amRNSDirector / PDMR Shareholding
27th Jun 202310:47 amRNSNotification of Major Holdings
22nd Jun 202312:35 pmRNSAnnual Report & Notice of AGM
19th Jun 20238:35 amRNSNotification of Major Holdings
15th Jun 20239:51 amRNSDirector LTIP Award
7th Jun 20237:00 amRNSPreliminary results
1st Jun 20232:50 pmRNSNotification of Major Holdings
30th May 20237:00 amRNSAppointment of Non-Executive Director
18th May 20231:33 pmRNSNotification of Major Holdings
17th May 202310:25 amRNSNotice of Full Year Results
19th Apr 20237:00 amRNSFull Year Trading Update
18th Apr 20237:00 amRNSNotification of Major Holdings
29th Mar 20235:47 pmRNSNotification of Major Holdings
15th Mar 20233:53 pmRNSNotification of Major Holdings
15th Mar 20238:37 amRNSNotification of Major Holdings
15th Mar 20237:00 amRNSNotification of Major Holdings
23rd Feb 20232:58 pmRNSNotification of Major Holdings
20th Feb 20239:48 amRNSNotification of Major Holdings
15th Feb 20235:33 pmRNSNotification of Major Holdings
13th Feb 202311:36 amRNSNotification of Major Holdings
25th Jan 20237:00 amRNSQ3 Trading Update and Acquisition Completion
6th Jan 20231:41 pmRNSNotification of Major Holdings
6th Jan 20238:24 amRNSNotification of Major Holdings
3rd Jan 202310:38 amRNSNotification of Major Holdings
22nd Dec 20227:00 amRNSAcquisition of Magnasphere Corporation
14th Dec 20224:31 pmEQSParadigm Biopharmaceuticals (PAR): Adapted therapies to meet unmet demand
5th Dec 20229:53 amEQSdiscoverIE Group (DSCV): Focused on sustainable growth
2nd Dec 202212:58 pmRNSNotification of Major Holdings
2nd Dec 20228:37 amRNSNotification of Major Holdings
23rd Nov 202212:01 pmEQSdiscoverIE Group profits jump in 'very strong first half'
23rd Nov 20227:00 amRNSdiscoverIE Commits to Net Zero Emissions
23rd Nov 20227:00 amRNSInterim Results
21st Nov 20223:38 pmRNSNotification of Major Holdings
16th Nov 20228:58 amRNSTR-1: Notification of Major Holdings
14th Nov 20223:41 pmRNSIssue of Equity & Total Voting Rights
1st Nov 202212:08 pmRNSNotice of Half Year Results
1st Nov 20227:00 amRNSDirectorate Changes
14th Oct 20224:56 pmRNSNotification of Major Holdings
13th Oct 20223:31 pmRNSTR-1: Notification of major holdings
13th Oct 20227:00 amRNSFirst Half Trading Update
11th Oct 202211:42 amRNSNotification of Major Holdings
5th Oct 20227:52 amRNSNotification of Major Holdings
5th Oct 20227:52 amRNSNotification of Major Holdings
28th Sep 20227:36 amRNSDirector Declaration
2nd Sep 202210:26 amRNSNotification of Major Holdings

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.